Xtrana & Trinity settle haemostasis suit
This article was originally published in Clinica
Executive Summary
Nucleic acid extraction and detection firm Xtrana and diagnostics group Trinity Biotech have resolved a dispute involving the latter's acquisition of the former's haemostasis business, Biopool, in December 2001.